Michele Brischigliaro1, Alfredo Cabrera-Orefice2, Mattia Sturlese3, Dei M Elurbe4, Elena Frigo1, Erika Fernandez-Vizarra1,5, Stefano Moro3, Martijn A Huynen4, Susanne Arnold2,6, Carlo Viscomi1, Massimo Zeviani5,7. 1. Department of Biomedical Sciences, University of Padova, Padova, Italy. 2. Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Molecular Modeling Section, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy. 4. Centre for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, The Netherlands. 5. Veneto Institute of Molecular Medicine, Padova, Italy. 6. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. 7. Department of Neurosciences, University of Padova, Padova, Italy.
Abstract
The mitochondrial respiratory chain (MRC) is composed of four multiheteromeric enzyme complexes. According to the endosymbiotic origin of mitochondria, eukaryotic MRC derives from ancestral proteobacterial respiratory structures consisting of a minimal set of complexes formed by a few subunits associated with redox prosthetic groups. These enzymes, which are the "core" redox centers of respiration, acquired additional subunits, and increased their complexity throughout evolution. Cytochrome c oxidase (COX), the terminal component of MRC, has a highly interspecific heterogeneous composition. Mammalian COX consists of 14 different polypeptides, of which COX7B is considered the evolutionarily youngest subunit. We applied proteomic, biochemical, and genetic approaches to investigate the COX composition in the invertebrate model Drosophila melanogaster. We identified and characterized a novel subunit which is widely different in amino acid sequence, but similar in secondary and tertiary structures to COX7B, and provided evidence that this object is in fact replacing the latter subunit in virtually all protostome invertebrates. These results demonstrate that although individual structures may differ the composition of COX is functionally conserved between vertebrate and invertebrate species.
The mitochondrial respiratory chain (MRC) is composed of four multiheteromeric enzyme complexes. According to the endosymbiotic origin of mitochondria, eukaryotic MRC derives from ancestral proteobacterial respiratory structures consisting of a minimal set of complexes formed by a few subunits associated with redox prosthetic groups. These enzymes, which are the "core" redox centers of respiration, acquired additional subunits, and increased their complexity throughout evolution. Cytochrome c oxidase (COX), the terminal component of MRC, has a highly interspecific heterogeneous composition. Mammalian COX consists of 14 different polypeptides, of which COX7B is considered the evolutionarily youngest subunit. We applied proteomic, biochemical, and genetic approaches to investigate the COX composition in the invertebrate model Drosophila melanogaster. We identified and characterized a novel subunit which is widely different in amino acid sequence, but similar in secondary and tertiary structures to COX7B, and provided evidence that this object is in fact replacing the latter subunit in virtually all protostome invertebrates. These results demonstrate that although individual structures may differ the composition of COX is functionally conserved between vertebrate and invertebrate species.
Cytochrome c oxidase (COX), also known as complex IV (CIV), is the terminal multiheteromeric enzyme of the mitochondrial respiratory chain (MRC). COX, which is part of the heme‐copper oxidase superfamily, catalyzes the oxidation of cytochrome c and the reduction of dioxygen to water. The eukaryotic mitochondrial COX is an aa‐type oxidase, sharing similarities with that found in some prokaryotes (Pereira et al, 2001; Esposti, 2020). However, the exact molecular evolution of this enzyme is still obscure. Bacterial aa oxidases form the minimal catalytically active unit of COX. They are composed of only three polypeptides (commonly named as COX1, COX2, and COX3). COX1 contains two heme A moieties, forming the aa center, and a mononuclear copper center (CuB), whereas COX2 binds a binuclear copper center (CuA). Contrariwise, COX3 contains no prosthetic groups, but it is known to prevent the enzyme’s redox‐induced irreversible self‐damage via a phenomenon named “suicide inactivation” (Bratton et al, 1999; Sharma et al, 2015). During the evolution of eukaryotes, the genes encoding COX1, COX2, and COX3 were retained in the mitochondrial DNA (mtDNA). Like most MRC complexes, eukaryotic COX expanded throughout evolution, by acquiring a set of so‐called “ancillary” or “supernumerary” subunits (Huynen et al, 2013). Despite not directly involved in catalysis, the supernumerary subunits participate in the enzyme activity, by conferring structural stability to the core and/or tuning the enzyme kinetics (Čunátová et al, 2020). The importance of these subunits is underscored by the observation that, albeit very rare, their pathological mutations lead to COX deficiency and disease phenotypes in humans and animal models (Brischigliaro & Zeviani, 2021). Yeast COX contains nine ancillary subunits (named Cox4‐9, Cox12, Cox13, and Cox26; Hartley et al, 2019), whereas mammalian COX is composed of 11 subunits around the catalytic core (COX4, COX5A‐B, COX6A‐C, COX7A‐C, COX8, and NDUFA4/COXFA4; Zong et al, 2018). Yeast and mammalian COX species have been extensively studied during the last three decades and detailed structural data are now available. In contrast, COX composition and function in other eukaryotes has not been investigated in deep detail and the available information about the evolutionary conservation of the MRC complexes, and specifically of COX, is inferred by comparison of protein sequences. Drosophila melanogaster has been emerging as a suitable model organism for the study of mitochondrial biology and disease (Foriel et al, 2015, 2019; Brandt et al, 2017; Garcia et al, 2017; Thompson et al, 2018; Brischigliaro et al, 2019, 2021; Lieber et al, 2019; Murari et al, 2020; Scialò et al, 2020; Peruzzo et al, 2021). Therefore, it is important to define the detailed molecular composition and functional properties of the MRC complexes in this organism. For example, it is widely accepted that mammals and, more generally, the chordate phylum possess the largest version of COX, as specific subunits such as COX8A‐C and COX7B are not found outside this phylum. Specifically, comparative analysis of COX protein sequences between Homo sapiens and D. melanogaster revealed the presence of 10 out of 11 homologous supernumerary COX subunits, with COX7B outstanding and therefore being considered the evolutionarily most recent subunit, as present only in vertebrates (Szuplewski & Terracol, 2001; Pierron et al, 2012; van Esveld & Huynen, 2018).The “complexome profiling” method (Heide et al, 2012; Wittig & Malacarne, 2021; Cabrera‐Orefice et al, 2022) consists of the separation of proteins in native polyacrylamide gels (Blue Native PAGE, BN‐PAGE), coupled to mass spectrometry (MS) analyses of small consecutively cut gel slices. This technique has been exploited to determine the composition and distribution of the MRC complexes from different organisms (Heide et al, 2012; Kahlhöfer et al, 2017; Senkler et al, 2017; Evers et al, 2021; Páleníková et al, 2021). We have applied complexome profiling to study the MRC of D. melanogaster. The profiles of COX subunit‐derived peptide distribution allowed us to identify a novel protein physically associated with D. melanogaster COX, encoded by a gene of unknown function (CG7630). The CG7630 protein is indeed contained within the COX complexome‐specific peak, together with all the canonical COX subunits, with the notable exception of the “missing” subunit, COX7B. CG7630 is unique to but invariantly present within protostome pluricellular organisms and we show here that its drastic knockdown in vivo leads to severe COX deficiency and ultimately developmental lethality. By combining structure prediction and homology modeling of the whole COX from D. melanogaster with complementation studies, we demonstrated that CG7630 is the invertebrate counterpart of COX7B.In summary, we identified the allegedly missing COX subunit of pluricellular protostome invertebrates, that is, the functional ortholog of the vertebrate specific COX7B subunit, and showed that this subunit is essential for D. melanogaster COX activity. Our work demonstrates that, as in mammals, the protostome holoenzyme is in fact composed of 14 subunits and proves that complexome analysis and functional complementation, rather than just sequence similarity, are conclusive tools to establish the subunit composition of MRC complexes in different organisms.
Results
CG7630 encodes a putative novel COX subunit
To study the composition of D. melanogaster COX, we performed complexome profiling of digitonin‐solubilized mitochondria from wild‐type (w) flies (Fig 1A). As shown in Fig 1B, the migration profiles and abundance, as displayed by heat maps, of all the known “canonical” COX subunits show co‐migration in three main discrete peaks. The first, most abundant species, migrating at an apparent molecular mass of ca. 220 kDa, corresponds to the “monomeric” form of COX (IV1). The second species (ca. 460 kDa) corresponds to the predicted molecular mass of the “dimeric” COX structure (IV2). Finally, the third species, corresponding to a peak migrating at ca. 770 kDa, is the supercomplex IV+III2 (Fig 1B). The core COX subunits annotated in FlyBase https://flybase.org/reports/FBgg0000488.html), that is, COX1, COX2, and COX3, as well as the supernumerary subunits COX4, COX5A, COX5B, levy/COX6A, COX6B, cype/COX6C, COX7A1, CG34172/COX7A2, and COX8, were all detected in our MS analysis. The only exception was COX7C, although the D. melanogaster proteome includes two polypeptides (COX7C and COX7CL) sharing high sequence identity with mammalian COX7C (35 and 46%, respectively). Notably, ND‐MLRQ, the fly ortholog of mammalian NDUFA4, initially thought to belong to complex I (Carroll et al, 2006) but more recently demonstrated to be a COX subunit in mammals (Balsa et al, 2012; Pitceathly et al, 2013; Zong et al, 2018), co‐migrates with the other COX subunits in our samples, confirming that the subunit is indeed a component of COX also in D. melanogaster (Garcia et al, 2017).
Figure 1
Identification of CG7630 as a novel subunit of cytochrome c oxidase (COX)
Scheme of a complexome profiling experiment. Mitochondrial from adult D. melanogaster individuals were isolated and subjected to native electrophoresis after solubilization with a mild detergent (digitonin). Natively separated complexes were excised from the gel in 60 slices, each subjected to MS analysis. Peptide mass fingerprinting profile distribution throughout the gel lane was analyzed and shown as complexome profiles.
MS profiles depicted as heatmaps and relative abundance of MRC enzymes in natively separated complexes from wild‐type fly mitochondria. Profiles of complexes I, III2 and V (CI, CIII and CV) are reported as average migration profiles of their specific subunits identified by MS. Canonical COX subunits migrate as enzyme monomer (IV1), dimer (IV2) and together with dimeric complex III as supercomplex (IV1 + III2). A novel protein product of a gene with unknown function (CG7630) co‐migrates with canonical COX subunits.
Identification of CG7630 as a novel subunit of cytochrome c oxidase (COX)
Scheme of a complexome profiling experiment. Mitochondrial from adult D. melanogaster individuals were isolated and subjected to native electrophoresis after solubilization with a mild detergent (digitonin). Natively separated complexes were excised from the gel in 60 slices, each subjected to MS analysis. Peptide mass fingerprinting profile distribution throughout the gel lane was analyzed and shown as complexome profiles.MS profiles depicted as heatmaps and relative abundance of MRC enzymes in natively separated complexes from wild‐type fly mitochondria. Profiles of complexes I, III2 and V (CI, CIII and CV) are reported as average migration profiles of their specific subunits identified by MS. Canonical COX subunits migrate as enzyme monomer (IV1), dimer (IV2) and together with dimeric complex III as supercomplex (IV1 + III2). A novel protein product of a gene with unknown function (CG7630) co‐migrates with canonical COX subunits.Hierarchical clustering of the complexome profiles, obtained from D. melanogaster mitochondria, revealed that two peptides that are part of a 90‐amino acid protein product encoded by a gene with unknown function named CG7630 – FlyBase ID FBgn0040793, and located on chromosome 3, were consistently found in the same cluster containing the canonical COX subunits, (Fig 1B). The abundance profile of CG7630 showed a consistent co‐migration pattern with all the identified COX subunits.
CG7630 is a bona fide COX subunit
Our results suggested that CG7630 is likely to be a previously uncharacterized COX supernumerary subunit. To further corroborate this hypothesis, we first tested whether CG7630 encodes a mitochondrially targeted protein. We expressed a C‐terminal HA‐tagged recombinant variant of CG7630 in D. melanogaster embryonic cells (S2R+), (Fig 2A), visualized its subcellular localization by immunofluorescence with anti‐HA antibodies and compared its distribution with that of ATP5A (subunit alpha of ATP synthase, which is contained in mitochondrial cristae). As shown in Fig 2B, CG7630 unequivocally co‐localized with the mitochondrial marker ATP5A, indicating that it is imported into the organelle. We then asked whether mitochondrial import of CG7630 depends on the presence of a mitochondrial targeting sequence (MTS). The analysis of CG7630 sequence with a mitochondrial prediction software, MitoFates (Fukasawa et al, 2015), identified a potential targeting sequence encompassing the first 23 N‐terminal amino acids, with a putative cleavage site for the mitochondrial processing peptidase (MPP) at position 22. To understand whether CG7630 has a MTS, we generated synthetic protein constructs (Fig 2A). The deletion of amino acids 2–23 (CG7630Δ2–23) abrogated the mitochondrial localization of CG7630‐HA (Fig 2B). Moreover, fusion of the first 23 amino acids of CG7630 (CG76301–23) to a GFP reporter targeted the GFP to mitochondria (Fig 2B). These results confirmed that the N‐terminus of CG7630 does contain a mitochondrial targeting sequence (MTS) consistent with results from MS analysis, which repeatedly detected two CG7630 tryptic peptides that correspond to the predicted mature part of the protein, encompassing amino acids 23–90.
Figure 2
CG7630 is a mitochondrial protein imported via an N‐terminal MTS
Scheme of synthetic constructs used to determine the subcellular localization of CG7630.
Confocal micrographs show the MTS‐dependent mitochondrial localization of CG7630. Embryonic S2R+ cells were transfected with GFP‐carrying the empty vector (EV:GFP), and vectors expressing HA‐tagged CG7630 protein (CG7630‐HA), a mutant CG7630‐HA carrying a deletion in the putative MTS (CG7630) and a mutant consisting of CG7630 putative MTS fused with the GFP reporter (CG7630). Scale bar: 5 μm.
CG7630 is a mitochondrial protein imported via an N‐terminal MTS
Scheme of synthetic constructs used to determine the subcellular localization of CG7630.Confocal micrographs show the MTS‐dependent mitochondrial localization of CG7630. Embryonic S2R+ cells were transfected with GFP‐carrying the empty vector (EV:GFP), and vectors expressing HA‐tagged CG7630 protein (CG7630‐HA), a mutant CG7630‐HA carrying a deletion in the putative MTS (CG7630) and a mutant consisting of CG7630 putative MTS fused with the GFP reporter (CG7630). Scale bar: 5 μm.To genetically test whether CG7630 encodes a subunit of COX, we knocked‐down (KD) the expression of CG7630 in vivo, by expressing a 128‐bp inverted repeat DNA sequence corresponding to a region of the CG7630 cDNA, through the GAL4/UAS system. We crossed the UAS responder fly line (CG7630) with a strong ubiquitous driver line (act5c‐gal4) to obtain RNAi progeny (act5c‐gal4>CG7630). Transgenic CG7630 KD individuals showed loss of ca. 80% of transcript expression measured by qPCR (Fig 3A). CG7630 KD progeny developed until the 3rd larval stage but eventually failed to reach pupation (Fig 3B and C). The developmental arrest correlated with severe reduction of COX activity in isolated mitochondria from CG7630 KD larvae, to approximately 55% of the controls (act5c‐gal4>+, Fig 3D). CIII activity was slightly reduced as well (ca. 10%, Fig 3D) and CII activity was slightly increased (ca. 10%), possibly reflecting an induction of mitochondrial biogenesis, as frequently observed in human samples with COX deficiency (Brischigliaro & Zeviani, 2021). To investigate how the activity deficiency correlates with assembly defects of the enzyme, we solubilized mitochondria from CG7630 KD and control larvae with n‐dodecyl‐β‐D‐maltoside (DDM) and separated the MRC complexes by BN‐PAGE. CI, CII, CIII, and CIV were specifically detected using either in‐gel activity (IGA) assays or Western blot (WB) immune‐visualization, using specific antibodies against one subunit for each complex. As shown in Fig 3E, IGA revealed strong reduction in the band corresponding to COX and a slight increase in succinate dehydrogenase (CII) activity, reflecting the spectrophotometric measurement of enzymatic activities. Additionally, WB immunodetection of COX from BN‐PAGE using an antibody against the COX4 subunit showed that the decreased activity corresponded to severely reduced COX content in CG7630 KD mitochondria (Fig 3F). Conversely, no differences were observed for CI and CII, whereas CIII was marginally affected, in agreement with our kinetic measurements (Fig 3D). Notably, COX4 steady‐state levels were also reduced by KD of CG7630 (Fig 3G), whereas other MRC complexes' subunits (SDHA, part of CII, and UQCR‐C2, part of CIII) were unaffected.
Figure 3
CG7630 is a bona fide COX subunit
Relative quantification (RQ) of CG7630 transcript after RNAi with a 120‐bp inverted‐repeat sequence (act5c‐gal4>UAS‐CG7630) compared to control (act5c‐gal4>+). Data are plotted as mean ± SD (n = 3 biological replicates, Student’s t test ***P = 0.0005).
Relative percentage of egg to adult viability of CG7630 RNAi cross (act5c‐gal4/CyO.GFP x UAS‐CG7630) and control cross (act5c‐gal4/CyO.GFP x w), calculated at three developmental stages (eggs, pupae, and adults), (n > 250, Chi‐square test 9.920 df(2), **P = 0.007).
Mendelian frequencies of adults obtained by crossing heterozygous act5c‐gal4>CyO.GFP flies with w genetic background flies (+/+) (n = 388 individuals, Chi‐square test 0.2527, df(1), P = 0.6152), and by crossing heterozygous act5c‐gal4>CyO.GFP flies with homozygous UAS‐CG7630 flies (n = 340 individuals, Chi‐square test 226.7, df(1), ****P < 0.0001).
Kinetic enzyme activity of individual MRC complexes in CG7630 RNAi and control individuals normalized by citrate synthase (CS) activity. Data are plotted as mean ± SD (n = 3 biological replicates, two‐way ANOVA with Sidak’s multiple comparisons, *P ≤ 0.05, ****P ≤ 0.0001).
In gel‐activity assays for MRC complexes II and IV in DDM‐solubilized mitochondria from RNAi (act5c‐gal4>UAS‐CG7630) and control larvae (act5c‐gal4>+).
BN‐PAGE, Western blot immunodetection of MRC complexes from CG7630 RNAi (act5c‐gal4>UAS‐CG7630) and control (act5c‐gal4>+) larvae using antibodies against specific subunits: anti‐UQCRC2 (complex III), anti‐NDUFS3 (complex I), anti‐COX4 (complex IV) and anti‐SDHA (complex II).
Western blot analysis of steady‐state levels (SDS‐PAGE) of MRC subunits COX4 (complex IV), SDHA (complex II) and UQCR‐C2 (complex III) in whole lysates from CG7630 RNAi (act5c‐gal4>UAS‐CG7630) and control (act5c‐gal4>+) larvae.
Western blot analysis of anti‐HA affinity purified samples from S2R+ D. melanogaster cells. EV = samples from cells carrying the empty expression vector. CG7630‐HA = samples from cells expressing HA‐tagged CG7630. Tot = total mitochondrial‐enriched fractions; unb = unbound material; IP:HA = immunoprecipitated material. Samples were probed with antibodies against MRC subunits of complexes I (NDUFS3), II (SDHA), III (UQCR‐C2), IV (COX4), and V (ATP5A).
Source data are available online for this figure.
CG7630 is a bona fide COX subunit
Relative quantification (RQ) of CG7630 transcript after RNAi with a 120‐bp inverted‐repeat sequence (act5c‐gal4>UAS‐CG7630) compared to control (act5c‐gal4>+). Data are plotted as mean ± SD (n = 3 biological replicates, Student’s t test ***P = 0.0005).Relative percentage of egg to adult viability of CG7630 RNAi cross (act5c‐gal4/CyO.GFP x UAS‐CG7630) and control cross (act5c‐gal4/CyO.GFP x w), calculated at three developmental stages (eggs, pupae, and adults), (n > 250, Chi‐square test 9.920 df(2), **P = 0.007).Mendelian frequencies of adults obtained by crossing heterozygous act5c‐gal4>CyO.GFP flies with w genetic background flies (+/+) (n = 388 individuals, Chi‐square test 0.2527, df(1), P = 0.6152), and by crossing heterozygous act5c‐gal4>CyO.GFP flies with homozygous UAS‐CG7630 flies (n = 340 individuals, Chi‐square test 226.7, df(1), ****P < 0.0001).Kinetic enzyme activity of individual MRC complexes in CG7630 RNAi and control individuals normalized by citrate synthase (CS) activity. Data are plotted as mean ± SD (n = 3 biological replicates, two‐way ANOVA with Sidak’s multiple comparisons, *P ≤ 0.05, ****P ≤ 0.0001).In gel‐activity assays for MRC complexes II and IV in DDM‐solubilized mitochondria from RNAi (act5c‐gal4>UAS‐CG7630) and control larvae (act5c‐gal4>+).BN‐PAGE, Western blot immunodetection of MRC complexes from CG7630 RNAi (act5c‐gal4>UAS‐CG7630) and control (act5c‐gal4>+) larvae using antibodies against specific subunits: anti‐UQCRC2 (complex III), anti‐NDUFS3 (complex I), anti‐COX4 (complex IV) and anti‐SDHA (complex II).Western blot analysis of steady‐state levels (SDS‐PAGE) of MRC subunits COX4 (complex IV), SDHA (complex II) and UQCR‐C2 (complex III) in whole lysates from CG7630 RNAi (act5c‐gal4>UAS‐CG7630) and control (act5c‐gal4>+) larvae.Western blot analysis of anti‐HA affinity purified samples from S2R+ D. melanogaster cells. EV = samples from cells carrying the empty expression vector. CG7630‐HA = samples from cells expressing HA‐tagged CG7630. Tot = total mitochondrial‐enriched fractions; unb = unbound material; IP:HA = immunoprecipitated material. Samples were probed with antibodies against MRC subunits of complexes I (NDUFS3), II (SDHA), III (UQCR‐C2), IV (COX4), and V (ATP5A).Source data are available online for this figure.To unequivocally demonstrate whether CG7630 is a bona fide COX subunit, we performed affinity purification of CG7630‐HA expressed in D. melanogaster S2R+ cells. As shown in Fig 3H, COX4 efficiently co‐immunoprecipitated with affinity captured HA‐tagged CG7630 under native conditions, whereas subunits of other MRC complexes, including NDUFS3 (CI), SDHA (CII), UQCR‐C2 (CIII), and ATP5A (CV) failed to co‐immunoprecipitate with CG7630‐HA (Fig 3H).
Homology of CG7630 and COX7B
Using sequence‐based methods, homologs of COX7B have been detected throughout the vertebrate lines, but not outside that phylum (van Esveld & Huynen, 2018). We used HHpred (Söding et al, 2005; Hildebrand et al, 2009), based on the prediction of functional‐structural information according to comparisons based on hidden Markov modeling, to launch COX7B as a bait for screening the D. melanogaster proteome. Interestingly, we obtained CG7630 and gomdanji as the best hits (E = 0.46 and E = 0.24 respectively, Fig EV1). Furthermore, a reciprocal search with CG7630 against the human proteome detected COX7B as the best hit (E = 3). Notably, such E values are higher than the generally accepted cutoff scores for considering two proteins as homologous. However, as CG7630 and COX7B were clearly part of the same protein complex (COX), the E value could be lowered by a factor of ~1,000, making similarity highly significant. We failed to detect orthologs of gomdanji outside the Drosophila genus, and therefore, we did not analyze it further.
Figure EV1
Alignment of COX7B with D. melanogaster proteins gomdanji and CG7630
HHpred was run with the mature COX7B protein against the D. melanogaster proteome using default settings.
Alignment of COX7B with D. melanogaster proteins gomdanji and CG7630
HHpred was run with the mature COX7B protein against the D. melanogaster proteome using default settings.
Phylogenetic distribution of CG7630/COX7B
Using Jackhmmer (Potter et al, 2018), homologs of CG7630 can be detected in the major taxa of the protostome taxonomic branch for which genomes are available: Arthropoda, Nematoda, Platyhelminthes, Mollusca, Tardigrada, Annelida, Bryozoa, Brachiopoda, and Rotifera. CG7630 appears ubiquitous among the protostomes, as in more than 91% of the species that have a homolog of the well‐conserved nuclear encoded subunit COX6A, we found a CG7630 homolog as well. Also, the CG7630 homologs were never lost in multiple species of a genus: that is, the absence of detectable homologs in a species appears to be due to incomplete genomes, gene prediction issues or undetectable homologs. We re‐examined the phylogenetic distribution of COX7B, as homologs among the non‐vertebrate Deuterostomia are undetected using Jackhmmer. We found a COX7B homolog in a nucleic acid sequence of the hemichordate Saccoglossus kowaleski (NCBI gene ID LOC100373479). Notably, although the two proteins are clearly distinct in D. melanogaster, we observed a number of instances in protostomes, where a homolog CG7630 is fused to the Apoptosis Inducing Factor (AIF) gene, for example, in Barnacles (A0A6A4VL42_AMPAM), Octopus (A0A7E6EJ31_OCTVU), and Daphnia (A0A0P5E3W8_9CRUS).
Evolution of COX subunits
We established the presence of COX7B homologs in the two main branches of the bilateria: the deuterostomia (such as human and S. kowaleski) and the protostomia (such as D. melanogaster). This observation, combined with the absence of detectable homologs “pre‐bilaterian” metazoan such as the cnidaria or the porifera argues for the origin of this subunit at the ancestral divergence point of bilateria. A number of other OXPHOS supernumerary proteins start appearing at the origin of bilateria (Fig 4A, Dataset EV1), including one other protein of the COX complex, COX8A (van Esveld & Huynen, 2018). Interestingly, COX8A and COX7B form two parallel TM helices close to each other at the same side of the COX complex (Zong et al, 2018), opposite the COX dimerization interface (Fig EV2). CG7630 contains, in contrast with COX7B, an insertion of ~20 amino acids at the N‐terminus of the mature protein (Fig 4B) that would protrude into the matrix. This region is well conserved among its protostome homologs, including the gomdanji protein and, together with the transmembrane (TM) helix, is annotated as the deltamethrin resistance domain. The name of that domain also found in gomdanji protein is based on its presence in prag01, a protein associated with deltamethrin resistance in Culex pipiens pallens (Zhang et al, 2011). However, deltamethrin is not known to interact with COX.
Figure 4
Phylogenetic distribution of CG7630/COX7B suggests it emerged at the root of bilateria
Scheme of the evolution of subunits part of human cytochrome c oxidase, sorted by their evolutionary origin, with the oldest subunits on the left. Subunits colored in red date back to bacteria. Orange indicates subunits with a common ancestor at the root of eukaryotes. Subunits shared between animals and fungi (opisthokonts) are in yellow while subunits dating at the origin of bilateria are in green. Blue is for the subunit that can be traced back to the deuterostomia and purple is for the subunits originated after the origin of deuterostomia. Note that the most recent subunits originate from gene duplications.
Alignment of the sequence logos of COX7B and CG7630. The sequence logos were created with weblogo (https://weblogo.berkeley.edu/) using alignments obtained from Jackhmmer. The positions that are conserved between the profiles (Fig EV1) are indicated with vertical lines, and the (predicted) TM helix is indicated with a horizontal line. The amino acid positions are based on the mature protein. Relative to COX7B, CG7630 has a 20 amino acid insertion close to the N terminus of the mature protein.
Figure EV2
COX (5Z62) with subunits colored by their evolutionary origin
The color code is the same that was used in Fig 5. Note that youngest subunits COX7B and COX8A are close together in the structure, suggesting a common reason for their origin.
Phylogenetic distribution of CG7630/COX7B suggests it emerged at the root of bilateria
Scheme of the evolution of subunits part of human cytochrome c oxidase, sorted by their evolutionary origin, with the oldest subunits on the left. Subunits colored in red date back to bacteria. Orange indicates subunits with a common ancestor at the root of eukaryotes. Subunits shared between animals and fungi (opisthokonts) are in yellow while subunits dating at the origin of bilateria are in green. Blue is for the subunit that can be traced back to the deuterostomia and purple is for the subunits originated after the origin of deuterostomia. Note that the most recent subunits originate from gene duplications.Alignment of the sequence logos of COX7B and CG7630. The sequence logos were created with weblogo (https://weblogo.berkeley.edu/) using alignments obtained from Jackhmmer. The positions that are conserved between the profiles (Fig EV1) are indicated with vertical lines, and the (predicted) TM helix is indicated with a horizontal line. The amino acid positions are based on the mature protein. Relative to COX7B, CG7630 has a 20 amino acid insertion close to the N terminus of the mature protein.
COX (5Z62) with subunits colored by their evolutionary origin
The color code is the same that was used in Fig 5. Note that youngest subunits COX7B and COX8A are close together in the structure, suggesting a common reason for their origin.
Figure 5
The 14‐subunit model of Drosophila melanogaster COX enzyme
The front and side view of CG7630, panel (A and B), respectively, is reported using the red ribbon and its molecular surface is in transparent red against the other COX subunits in gray‐white. The inner mitochondrial membrane is reported in dark gray.
In panel C, the ribbon representation is extended to the whole enzyme.
In panel D, each subunit is shown as a ribbon in different colors.
Panel E shows Drosophila melanogaster atomic model of CG7630 and COX4 helices (red) interactions compared to the human COX7B‐COX4 interactions (yellow). The conserved residues, located in the proximity of the intermembrane space and involved the helix‐helix interactions, are highlighted using stick representation and the distance of the observed H‐bonds are displayed.
Molecular modeling of D. melanogaster COX with CG7630
As no structural data for COX from any invertebrate animal are available, we used a hybrid strategy to generate a 3D model (Fig 5A–D) of the whole 14‐subunit architecture of D. melanogaster COX including CG7630. Specifically, we combined structural homology data with high‐resolution x‐ray diffraction and cryo‐EM reference structures of mammalian COX and artificial intelligence‐based predictions from the AlphaFold database (Jumper et al, 2021; Varadi et al, 2022). As the remote homology detection based on HMMs profile comparison suggested the structure of bovine COX (PDB ID: 2Y69; Kaila et al, 2011) as the most suitable template for CG7630, we used this 13‐subunit structure as the primary template. The cryo‐EM structural information of human COX PDB ID 5Z62 (Zong et al, 2018) was used to recover NDUFA4/COXFA4 subunit (Pitceathly & Taanman, 2018). To obtain a model of the N‐terminus of CG7630 (residues 23–51), that is missing in mammals, we included the coordinates obtained from AlphaFold predictions for this domain. The final model clearly retraces the typical COX topology and CG7630 obtained by the hybrid method nicely adapts to the holoenzyme (Fig 5A–D). The homologous region between COX7B and CG7630 covers the COX7B transmembrane helix and part of COX7B portion protruding into the intermembrane space (IMS). The TM segment of CG7630 is in close contact with COX4. The most conserved region is in the TM helix, mainly close to the matrix. Notably, in this segment of CG7630 a pattern relevant for the interaction with COX4 can be identified, which is also present in COX7B (Fig 5E). Thus, the Asp56 in CG7630 can retain the H‐bond interaction with the Lys75 of COX4, similar to the interaction of Asp39 and Lys101 in the human COX7B/COX4 bound structure. In D. melanogaster, this interaction could be even more strongly stabilized by the presence of a second Asn in position 52, the sidechain of which is still orientated toward Lys75 (Fig 5E). Likewise, the hydrophobic residue Leu59, also facing COX4, is preserved (corresponding to Leu42 in COX7B, Fig 5E). The closest point between the TM domains of CG7630 and COX4 occurs at position Gly62 of CG7630 (corresponding to Gly45 in COX7B) is necessary to maintain the appropriate distance as the absence of the sidechain is likely to favor the helix contacts (Fig 5E).
The 14‐subunit model of Drosophila melanogaster COX enzyme
The front and side view of CG7630, panel (A and B), respectively, is reported using the red ribbon and its molecular surface is in transparent red against the other COX subunits in gray‐white. The inner mitochondrial membrane is reported in dark gray.In panel C, the ribbon representation is extended to the whole enzyme.In panel D, each subunit is shown as a ribbon in different colors.Panel E shows Drosophila melanogaster atomic model of CG7630 and COX4 helices (red) interactions compared to the human COX7B‐COX4 interactions (yellow). The conserved residues, located in the proximity of the intermembrane space and involved the helix‐helix interactions, are highlighted using stick representation and the distance of the observed H‐bonds are displayed.
Human COX7B can rescue COX deficiency in D. melanogaster cells
To determine whether CG7630 and human COX7B (hCOX7B) are in fact orthologs, we performed functional complementation assays. We generated stable S2R+ D. melanogaster cell lines carrying the pAc5‐STABLE2‐neo vector in which we cloned C‐terminally HA‐tagged forms of either CG7630 or hCOX7B. Then, we performed targeted RNAi via soaking cultured cells with synthetic dsRNAs (Clemens et al,
2000) targeting CG7630, which induced > 95% reduction of the CG7630 transcript in wild‐type S2R+ cells (Fig 6A). Then, we checked the expression of rescue constructs in CG7630 KD cells. hCOX7B‐HA and CG7630‐HA transcripts were expressed (Fig 6B) and translated into proteins (Fig 6C). The expression of CG7630 transcript in cells carrying the CG7630‐HA construct was 5‐fold higher than that of cells carrying the empty vector (EV), and therefore expressing only endogenous CG7630. In CG7630‐HA expressing cells, exposure to dsRNA against CG7630 reduced transcript levels of CG7630 (Fig 6B), which, however, remained still 2.6‐fold higher than those found in the EV control cells treated with mock dsRNA. Accordingly, CG7630‐HA levels were decreased in KD cells vs. non‐KD CG7630‐HA expressing cells (Fig 6C). When we measured COX activity in the EV control S2R+ cells exposed to dsRNA, we found that the KD of CG7630 suppressed COX activity by ~60% (Fig 6D). Expression of CG7630‐HA in these very cells determined a recovery of COX activity to values virtually identical to those of the EV, mock‐treated control cells (Fig 6D). Notably, when hCOX7B‐HA was expressed in fly cells in which the expression of CG7630 was knocked‐down, COX activity was significantly increased, reaching levels of ~70% of the mock‐treated control (EV) cells (Fig 6D). In addition, we tested the steady‐state levels of CI, CII, CIV, and CV subunits from whole‐cell lysates, separated by SDS–PAGE, and immunovisualized by WB with specific antibodies. As shown in Fig 6E, ATP5A (CV subunit) and SDHA (CII subunit) levels were affected neither by CG7630 KD nor by CG7630 or COX7B expression. Conversely, the COX4 immunoreactive band was severely reduced by CG7630 KD in EV cells. Again, the expression of hCOX7B partially rescued the levels of COX4 in CG7630 KD cells (Fig 6E), whereas full rescue, comparable to the levels found in mock‐treated control EV cells, was obtained in CG7630‐HA expressing cells. Taken together, these results demonstrated that the CG7630 protein is a necessary component for COX assembly and function in D. melanogaster, where it clearly plays the same role established in mammalian COX by COX7B.
Figure 6
Human COX7B can rescue COX deficiency caused by loss of CG7630
Relative quantification (RQ) of CG7630 transcript in wild‐type D. melanogaster S2R+ cells treated with a dsRNA targeting CG7630 (CG7630 KD) and a mock control dsRNA (mock). Data are plotted as mean ± SD (n = 3 biological replicates, Student’s t test ***P = 0.0005).
Relative quantification (RQ) of CG7630 and COX7B transcripts in stable S2R+ cell lines carrying the empty expression vector (EV:GFP;neo), and expression vectors carrying HA‐tagged forms of human COX7B (hCOX7B‐HA;neo) and CG7630 (CG7630‐HA;neo). Cells were treated with a dsRNA targeting CG7630 (striped bars, CG7630 KD) and a mock control dsRNA (solid bars, mock). N/D = not detected. Data are plotted as mean ± SD (n = 3 biological replicates, one‐way ANOVA with Dunnet’s multiple comparisons, *P = 0.0370, **P = 0.0074, ***P = 0.0003).
Immunoblot analysis of stable S2R+ cell lines carrying the empty expression vector (EV:GFP;neo), and expression vectors carrying HA‐tagged forms of human COX7B (hCOX7B‐HA;neo) and CG7630 (CG7630‐HA;neo). The CG7630 transcript was knocked‐down (KD) in cells by a dsRNA targeting CG7630 and compared with cells treated with a mock control dsRNA (mock). Samples were probed with an antibody anti‐HA tag and with an antibody against Hsp70 as an endogenous control.
Kinetic enzyme activity of COX normalized by citrate synthase activity (CS) in stable S2R+ cell lines carrying the empty expression vector (EV:GFP;neo), and expression vectors carrying HA‐tagged forms of human COX7B (hCOX7B‐HA;neo) and CG7630 (CG7630‐HA;neo). Cells were treated with a dsRNA targeting CG7630 (striped bars, CG7630 KD) and a mock control dsRNA (solid bars, mock). Data are plotted as mean ± SD (n = 3 biological replicates, two‐way ANOVA with Sidak’s multiple comparisons, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001).
Steady‐state levels of MRC subunits in samples from rescue experiment performed as in (D).
Source data are available online for this figure.
Human COX7B can rescue COX deficiency caused by loss of CG7630
Relative quantification (RQ) of CG7630 transcript in wild‐type D. melanogaster S2R+ cells treated with a dsRNA targeting CG7630 (CG7630 KD) and a mock control dsRNA (mock). Data are plotted as mean ± SD (n = 3 biological replicates, Student’s t test ***P = 0.0005).Relative quantification (RQ) of CG7630 and COX7B transcripts in stable S2R+ cell lines carrying the empty expression vector (EV:GFP;neo), and expression vectors carrying HA‐tagged forms of human COX7B (hCOX7B‐HA;neo) and CG7630 (CG7630‐HA;neo). Cells were treated with a dsRNA targeting CG7630 (striped bars, CG7630 KD) and a mock control dsRNA (solid bars, mock). N/D = not detected. Data are plotted as mean ± SD (n = 3 biological replicates, one‐way ANOVA with Dunnet’s multiple comparisons, *P = 0.0370, **P = 0.0074, ***P = 0.0003).Immunoblot analysis of stable S2R+ cell lines carrying the empty expression vector (EV:GFP;neo), and expression vectors carrying HA‐tagged forms of human COX7B (hCOX7B‐HA;neo) and CG7630 (CG7630‐HA;neo). The CG7630 transcript was knocked‐down (KD) in cells by a dsRNA targeting CG7630 and compared with cells treated with a mock control dsRNA (mock). Samples were probed with an antibody anti‐HA tag and with an antibody against Hsp70 as an endogenous control.Kinetic enzyme activity of COX normalized by citrate synthase activity (CS) in stable S2R+ cell lines carrying the empty expression vector (EV:GFP;neo), and expression vectors carrying HA‐tagged forms of human COX7B (hCOX7B‐HA;neo) and CG7630 (CG7630‐HA;neo). Cells were treated with a dsRNA targeting CG7630 (striped bars, CG7630 KD) and a mock control dsRNA (solid bars, mock). Data are plotted as mean ± SD (n = 3 biological replicates, two‐way ANOVA with Sidak’s multiple comparisons, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001).Steady‐state levels of MRC subunits in samples from rescue experiment performed as in (D).Source data are available online for this figure.
Discussion
The MRC of eukaryotes derives from evolutionary remodeling of minimal enzymatic units found in prokaryotes (Pereira et al, 2001; Esposti, 2020). Thus, it is currently well accepted that MRC complexes acquired more and more subunits and increased their complexity throughout evolution, with vertebrates and, more specifically, mammals having the largest and most multiheteromeric enzymes (Szuplewski & Terracol, 2001; Pierron et al, 2012; van Esveld & Huynen, 2018), although also the apicomplexa Plasmodium falciparum and Toxoplasma gondii have acquired a large set of new accessory subunits (Evers et al, 2021; Maclean et al, 2021). Detailed information about the functional or structural role of each of the COX supernumerary subunits is still lacking (Čunátová et al, 2020). The most studied subunit is COX4, for which it has been proposed a modulatory role in oxygen affinity in different tissues or under different energetic demands and oxygen availability (Fukuda et al, 2007; Hüttemann et al, 2007; Acin‐Perez et al, 2011; Pajuelo Reguera et al, 2020). Mammalian COX is considered the largest CIV species in metazoans, having one specific subunit—COX7B—that was never identified outside vertebrates due to lack of sequence homology.Here, we prove that this widely accepted concept is incorrect. We provide compelling evidence that invertebrate COX is composed of 14 subunits, as the mammalian enzyme, and that an evolutionary divergent protein with a non‐conserved amino acid sequence plays the same structural and functional role of mammalian COX7B. Specifically, by applying complexome profiling to D. melanogaster mitochondria, we identified a protein of previously unknown function, showing an identical migration profile to canonical COX subunits. This protein is encoded by an uncharacterized gene—CG7630—and is targeted to mitochondria through a canonical N‐terminal mitochondrial targeting sequence (MTS) which appears to be cleaved off the mature protein, according to our proteomic data. This suggests that the protein is processed by the mitochondrial matrix protein, as a canonical structure eventually targeted to the inner mitochondrial membrane.We showed that the knockdown of CG7630 in vivo leads to developmental arrest at the larval stage in D. melanogaster linked with severe reduction in COX enzyme activity, demonstrating that CG7630 encodes a bona fide COX subunit.The only COX subunit missing in the D. melanogaster proteome was COX7B. Although CG7630 and human COX7B have low sequence similarity, we demonstrate that, by biocomputational reconstruction, they share homology in secondary and tertiary structures (e.g., the hydrophobic TM‐helix) and possess conserved residues needed for docking its unique interactor, subunit COX4, in a manner similar to COX7B. Moreover, the fact that human COX7B is able to rescue defects in CG7630 KD cells conclusively proves that CG7630 and COX7B are functional orthologs.This work demonstrates that vertebrate and protostome COX complexes are structurally identical and that COX7B should not be considered as a functionally and structurally unique acquisition of the most recent animal phylum, vertebrates, but a homolog in deuterostomes of a subunit which is also present in protostomes. Whether COX7B confers additional, or specific, regulatory functions to the enzyme in vertebrates, including mammals, is still unknown. Likewise, the evolutionary mechanisms and possible functional implications of the divergence between the two “COX7B orthologs” in the two divisions of bilateria are unresolved issues. Unquestionably, this subunit has a relevant physiological and pathological role, since mutations in COX7B have been found in patients who suffer from mitochondrial disease with COX deficiency (Indrieri et al, 2012) and the knockdown of CG7630 is clearly deleterious for the COX activity in, and the development of, D. melanogaster. Indeed, CG7630 species appear to play the same role in pluricellular invertebrate animals as COX7B in chordates, the two superphyla of bilateria. For this reason, we propose to rename D. melanogaster CG7630 as COX7B‐like protein (COX7BL).Intriguingly, among the homologs of CG7630 in other protostomes, we observed proteins fused to an Apoptosis Inducing Factor (AIF). Consistent with the intermembrane space location of the AIF protein (Otera et al, 2005), the gene is fused with the C‐terminus of the CG7630 homolog, which is predicted to be in the intermembrane space. Remarkably, a very recent work showed that around 10% of mammalian COX interacts with AIF (Hevler et al, 2021). Our findings support the hypothesis that the fusion protein formed by the ortholog of CG7630+AIF, detected in some protostomes, has a functional role, which is carried out in deuterostomes by COX7B interacting with, but physically separated from AIF. It is likely, but still unproven, that the same interaction may occur between CG7630 and AIF, also in those protostome organisms, such as D. melanogaster, in which the two proteins are clearly distinct. Our work provides additional support to a newly identified and still unsolved functional partnership between COX and AIFM1‐encoded proteins whose physiological and pathological relevance will be investigated in the future.Our work provides a clear example of the power of proteomic approaches, such as complexome profiling, to overcome limitations given by evolutionary protein sequence divergence that add to the complexity of the MRC. Further work is warranted to deeply investigate and characterize the composition of all the respiratory complexes in standard invertebrate model—D. melanogaster—to help clarify MRC subunit composition and distribution throughout evolution.
Materials and Methods
Fly stocks and maintenance
Flies were raised on standard cornmeal medium and kept at 23°C, 70% humidity on a 12:12 h light/dark cycle. Fly strains used in this study were obtained from Bloomington Drosophila Stock Center (BDSC) and Vienna Drosophila Resource Center (VDRC). Genotypes used in this study were: w (BDSC), act5c‐gal4>CyO.GFP (BDSC 4414) and UAS‐CG7630‐IR (VDRC 107667). Control individuals were obtained by crossing the gal4 driver line with the genetic background flies w.
Isolation of mitochondria
Mitochondria from D. melanogaster larvae were prepared by differential centrifugation as described previously (Brischigliaro et al, 2022). Protein concentration of mitochondrial extracts was measured with the Bradford method (Bio‐Rad protein assay).
Complexome profiling
Isolated mitochondria were pelleted by centrifugation and the supernatant was discarded. Mitochondrial proteins (0.2 mg) were solubilized with 6 g digitonin/g protein in 50 mM NaCl, 5 mM 6‐aminohexanoic acid, 1 mM EDTA, 50 mM imidazole/HCl, pH 7.0. After centrifugation at 22,000 × g for 20 min at 4°C, the supernatant was supplemented with Coomassie brilliant blue G250 and proteins were separated by 4–16% gradient BN‐PAGE. Digitonin‐solubilized mitochondrial proteins from bovine heart were loaded as molecular mass standards. After electrophoresis, the gel was fixed and stained with Coomassie blue. Gel lanes were cut into 60 even pieces, each of which was cut into smaller pieces, transferred to a 96‐well filter microtiter plate (Millipore), and destained in 50% (v/v) methanol, 50 mM ammonium bicarbonate. After complete destaining, in‐gel digestion with trypsin was performed. Tryptic peptides were separated by liquid chromatography and analyzed by tandem mass spectrometry (LC‐MS/MS) in a Q‐Exactive 2.0 Orbitrap Mass Spectrometer (2.8 SP1) equipped with an Easy nLC1000 nano‐flow ultra‐high‐pressure liquid chromatography system (Thermo Fisher Scientific) at the front end. Thermo Scientific Xcalibur 3.1 Software Package was used for data recording. Mass spectrometry RAW data files were analyzed using MaxQuant (version 1.5.0.25). The extracted spectra were matched against the D. melanogaster Uniprot Reference Sequence database (release 2020_04). Database searches were done with 20 ppm match tolerances. Trypsin was selected as the protease with two missed cleavages allowed. Dynamic modifications included N‐terminal acetylation and oxidation of methionine. Cysteine carbamidomethylation was set as a fixed modification. Keratins, known contaminants, and trypsin were removed from the list. The abundance of each protein was determined by label‐free quantification using the composite intensity based absolute quantification (iBAQ) values determined by MaxQuant analysis and was corrected for loading and MS sensitivity variations between samples based on the total iBAQ value for all detected complex V subunits. Gel migration profiles were created for each protein and normalized to the maximum abundance. The profiles of the identified mitochondrial proteins were hierarchically clustered by distance measures based on Pearson correlation coefficient (uncentered) and the average linkage method using the NOVA software package v0.5 (Giese et al, 2015). The visualization and analysis of the heatmaps representing the normalized abundance in each gel slice by a three‐color code gradient (black/yellow/red) were made using Microsoft Excel 2019 and Graph Pad Prism 8.4.3. The mass calibration for the BN‐PAGE gels was performed as previously described (Guerrero‐Castillo et al, 2017). Membrane proteins were calibrated using the well‐known molecular masses of respiratory chain complexes and supercomplexes from bovine heart mitochondria. The soluble proteins were, however, calibrated using the following set of Drosophila proteins: ATPB (51 kDa), malate dehydrogenase (72 kDa, dimer), citrate synthase (100 kDa, dimer), ETFA/B (122, heterodimer), heat shock protein 60 (410 kDa, heptamer), ALDH7A1 (675 kDa, dodecamer).
RNA isolation, reverse transcription, and qRT‐PCR
Total RNA was extracted from 10 larvae for each genotype using TRIzol method (Thermo Fisher Scientific) according to the manufacturer's instructions. Reverse transcription was performed with the GoScript Reverse Transcriptase kit (Promega). qRT‐PCRs were performed using GoTaq qPCR SYBR Green chemistry (Promega) and a Bio‐Rad CFX 96 Touch System (Bio‐Rad). The method (relative quantification) was used to calculate the expression levels of the targets using Rp49 as endogenous control. The oligonucleotides used in this study are listed in the table of primers (Table 1).
Blue‐native polyacrylamide gel electrophoresis (BN‐PAGE) and in‐gel activity (IGA) assays
Isolated mitochondria were resuspended in 1.5 M aminocaproic acid, 50 mM Bis‐Tris/HCl pH 7.0. The samples were solubilized with 4 mg of n‐dodecyl‐β‐D‐maltoside (Sigma) per mg of protein. After 5 min of incubation on ice, samples were centrifuged at 18,000 × g at 4°C for 30 min. The supernatant was collected and resuspended with Sample Buffer (750 mM aminocaproic acid, 50 mM Bis‐Tris/HCl pH 7.0, 0.5 mM EDTA and 5% Serva Blue G). Native samples were separated using NativePAGE 3–12% Bis‐Tris gels (Thermo Fisher Scientific) according to the manufacturer’s protocol.For the detection of the activity of mitochondrial respiratory chain complexes, gels were stained with the following solutions. Complex II (succinate dehydrogenase): 5 mM Tris–HCl pH 7.4, 0.2 mM phenazine methosulfate (Sigma), 20 mM succinate, and 1 mg/ml nitrotetrazolium blue chloride; Complex IV (cytochrome c oxidase): 50 mM potassium phosphate pH 7.4, 1 mg/ml 3′,3′‐diaminobenzidine tetrahydrochloride hydrate (Sigma), 24 units/ml catalase from bovine liver (Sigma), 1 mg/ml cytochrome c from equine heart (Sigma), and 75 mg/ml sucrose.
Analysis of MRC activity
The activities of mitochondrial respiratory chain complexes and citrate synthase (CS) were measured by spectrophotometry, as described previously (Brischigliaro et al, 2022).
Western blot and immunodetection
BN‐PAGE gels were transferred to PVDF membranes in Dunn carbonate buffer (10 mM NaHCO3, 3 mM Na2CO3) applying a constant voltage of 25 V at 4°C for 1 h using a XCell IITM Blot Module (Thermo Fisher Scientific). SDS‐PAGE gels were transferred to PVDF membranes in Tris‐Glycine transfer buffer (25 mM Tris‐HCl, 192 mM Glycine, 20% methanol, 0.025% SDS) applying a constant voltage of 100 V at 4°C for 1 h using a Mini Trans‐Blot® Cell (Bio‐Rad). For the immunodetection of specific protein targets, blotted PVDF membranes were blocked in 5% skimmed milk in PBS‐T (0.1% Tween‐20) at room temperature for 1 h and then incubated overnight with primary antibodies diluted in 3% BSA in PBS‐T overnight at 4°C. After incubating the primary antibody, the PVDF membranes were washed three times with PBS‐T for 10 min, incubated with the secondary HRP‐ conjugated antibody for 1 h at room temperature and washed three times with PBS‐T for 10 min. Chemiluminescent signals were recorded using an Alliance Mini HD9 (UVITEC). Antibodies used are listed in the table of antibodies (Table 2).
Table 2
List of antibodies used in this study.
Antibody
Source
Cat. No./Ref
Application
Concentration
Mouse monoclonal anti‐NDUFS3
Abcam
ab14711
WB
1:1,000
Rabbit polyclonal anti‐COXIV
Cell Signaling Technology
4844
WB
1:1,000
Mouse monoclonal anti‐ATP5A
Abcam
ab14748
IF
1:200
Mouse monoclonal anti‐Hsp70
Sigma‐Aldrich
H5147
WB
1:1,000
Rabbit monoclonal anti‐HA
Cell Signaling Technology
3724
WB, IF
1:1,000, 1:300
Rabbit polyclonal anti‐UQCR‐C2
Dr. Edward Owusu‐Ansah
Murari et al (2020)
WB
1:2,000
Rabbit polyclonal anti‐Sdha
Dr. Edward Owusu‐Ansah
Murari et al (2020)
WB
1:2,000
Goat anti‐Mouse IgG
Promega
W402B
WB
1:5,000
Goat anti‐Rabbit IgG
Promega
W401B
WB
1:3,000
Goat anti‐rabbit Alexa Fluor 488
Thermo Fisher Scientific
A11008
IF
1:100
Goat anti‐mouse Alexa Fluor 647
Thermo Fisher Scientific
A32728
IF
1:200
List of antibodies used in this study.
Cell cultures and molecular cloning
The Drosophila S2R+ cell line is derived from a primary culture of late stage (20–24 h old) D. melanogaster embryos and was obtained from the Drosophila Genomics Resource Center (DGRC ID 150). S2R+ cells grow at 25°C without CO2 in Schneider’s medium (Biowest) with 10% heat‐inactivated fetal bovine serum (FBS; Euroclone). CG7630 and COX7B cDNAs were cloned in pAc5‐STABLE2‐neo vector (González et al, 2011) using In‐Fusion HD cloning kit (Takara Bio) according to the manufacturer’s instructions. Primers used for molecular cloning are listed in the table of primers (Table 1).
Co‐immunoprecipitation
Mitochondrial‐enriched fractions from S2R+ cells were solubilized under native conditions on ice for 10 min using PBS with 10% glycerol, 1.5% DDM, protease inhibitor cocktail and a mixture of polar lipids (Avanti polar lipids): 16:0–18:1 PC, 16:0–18:1 PE, 16:0–18:1 PG. Samples were centrifuged at 18,000 × g for 10 min at 4°C to remove insoluble material. Soluble fractions were incubated with monoclonal anti‐HA‐agarose beads (Sigma) overnight at 4°C under gentle rotation. Anti‐HA‐agarose beads were washed five times using PBS with 10% glycerol, 0.05% DDM, protease inhibitor cocktail and polar lipids. Immunoadsorbed complexes were eluted under denaturing conditions using 200 mM glycine pH 2.5 and samples were subsequently neutralized with unbuffered 1 M Tris.
Transfection and generation of stable cell lines
S2R+ cells were transfected in 12‐well plates using Effectene Transfection Reagent (Qiagen) according to the manufacturer's instructions. For immunofluorescence studies, cells were transiently transfected and analyzed 24 h after transfection. For functional complementation studies, stable cells were obtained through selection with geneticin G418 (Invivogen) at 1 mg/ml concentration for 30 days after transfection.
dsRNA synthesis and in vitro RNAi
Synthesis of dsRNA was performed using Ambion MEGAscript T7 Transcription Kit (ThermoFisher Scientific). dsRNAs for experiment and mock control treatment were synthesized using cDNA sequences from D. melanogaster CG7630 and human IGFBP2, respectively. The primers used for the amplification of T7 transcription template are listed in the table of primers (Table 1). For RNAi experiments, S2R+ cells were plated on 12‐well plates and treated for 1 h with 5 μg synthetic dsRNA in Schneider’s medium without serum. After treatment, serum was added and cells were harvested after 96 h.
Immunostaining and confocal microscopy
S2R+ cells were prepared for immunostaining and confocal microscopy as described previously (Benincá et al, 2021). The coverslips were mounted with Vectashield mounting medium (Vector Laboratories) and images were taken with a Zeiss LSM700 confocal microscope at 63× magnification. Antibodies used are listed Table 2.
Molecular modeling
Drosophila melanogaster cytochrome c oxidase model was built using the homology modeling protocol implemented in the MOE suite (Chemical Computing Group (CCG) Inc. (2020). Molecular Operating Environment (MOE). Chemical Computing Group. http://www.chemcomp.com). A multiple template strategy was achieved by selecting bovine COX structure PDB‐ID 2Y69 (Kaila et al, 2011, X‐ray Crystallography, Resolution: 1.9 Å), the human COX PDB‐ID 5Z62 (Zong et al, 2018, Cryo‐EM, Resolution: 3.60 Å) and Alphafold predicted structure (Uniprot: Q9VVG5, Jumper et al, 2021; Varadi et al, 2022) as templates. Human template was used to model NDUFA4/COXFA4 while the other 13 subunits were modeled on the bovine template. The mitochondrial targeting sequence at the N‐terminal of CG7630 was identified with the MitoFates server (Fukasawa et al, 2015) and not further considered in the model generation. The CG7630 segment (23–51) was obtained from the AlphaFold database (Jumper et al, 2021; Varadi et al, 2022) as the corresponding template structure was not experimentally solved. The sequences were aligned with MOE except for CG7630 which alignment with COX7B was obtained from HHpred (Söding et al, 2005; Hildebrand et al, 2009). All the experimentally derived templates were prepared with the MOE structure preparation tool to add hydrogen atoms, fix missing atoms, and assign partial charges, and finally superposed. The homology model was obtained generating 10 different models using Amber12 Force Field (Maier et al, 2015) and selecting the best one according to the GB/VI score.
Statistical analysis
Statistical analysis was performed with GraphPad Prism Software, version 8.2.1. Statistical tests and significance are described in the figure captions.
Author contributions
Michele Brischigliaro: Conceptualization; Data curation; Formal analysis; Validation; Investigation; Methodology; Writing—original draft; Writing—review and editing. Alfredo Cabrera‐Orefice: Data curation; Formal analysis; Investigation; Methodology. Mattia Sturlese: Investigation; Methodology; Writing—original draft. Dei M Elurbe: Investigation. Elena Frigo: Investigation. Erika Fernandez‐Vizarra: Supervision; Methodology. Stefano Moro: Supervision; Investigation; Methodology; Writing—original draft. Martijn A Huynen: Formal analysis; Funding acquisition; Investigation; Writing—original draft. Susanne Arnold: Data curation; Funding acquisition; Validation; Investigation; Writing—original draft. Carlo Viscomi: Supervision; Funding acquisition. Massimo Zeviani: Conceptualization; Supervision; Funding acquisition; Writing—original draft; Writing—review and editing.In addition to the CRediT author contributions listed above, the contributions in detail are:MB prepared samples for complexome profiling analysis and performed all the wet studies including molecular, cell biology, biochemical, and structural investigations, planning the experiments with MZ. ACO and SA performed the complexome profiling, analyzed and interpreted the data. MB, MS and SM performed the homology modelling study. EF contributed to RNAi validation, immunofluorescence, and phenotypical analyses. MB, DME and MH performed the phylogenetic analyses. CV and EFV provided technical advice and optimization. MZ conceived and supervised the project. MB and MZ wrote the manuscript. All authors discussed the results and contributed to the final version of the manuscript.
Disclosure and competing interests statement
The authors declare that they have no conflict of interest.Expanded View Figures PDFClick here for additional data file.Dataset EV1Click here for additional data file.Source Data for Figure 3Click here for additional data file.Source Data for Figure 6Click here for additional data file.
Authors: Cristiane Benincá; Vanessa Zanette; Michele Brischigliaro; Mark Johnson; Aurelio Reyes; Daniel Almeida do Valle; Alan J Robinson; Andrea Degiorgi; Anna Yeates; Bruno Augusto Telles; Julien Prudent; Enrico Baruffini; Mara Lucia S F Santos; Ricardo Lehtonen R de Souza; Erika Fernandez-Vizarra; Alexander J Whitworth; Massimo Zeviani Journal: J Med Genet Date: 2020-05-21 Impact factor: 6.318